VANGUARD GROUP INC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 126 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$18,269,882
+67.9%
3,822,151
+49.3%
0.00%
Q2 2023$10,880,982
-21.4%
2,560,231
-1.8%
0.00%
Q1 2023$13,838,183
-14.6%
2,606,061
+1.0%
0.00%
Q4 2022$16,203,763
-39.9%
2,580,217
+1.0%
0.00%
-100.0%
Q3 2022$26,939,000
+149.0%
2,553,428
+28.2%
0.00%
Q2 2022$10,818,000
-41.1%
1,992,363
-0.5%
0.00%
Q1 2022$18,375,000
+33.2%
2,001,554
+118.9%
0.00%
Q4 2021$13,799,000
-38.3%
914,516
-2.3%
0.00%
-100.0%
Q3 2021$22,351,000936,4000.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,266,04015.18%
Elmwood Wealth Management, Inc. 2,364,415$11,301,9045.45%
PFM Health Sciences, LP 6,724,715$32,144,1381.51%
SILVERARC CAPITAL MANAGEMENT, LLC 892,786$4,267,5171.29%
Avidity Partners Management LP 6,050,212$28,920,0131.16%
Paradigm Biocapital Advisors LP 2,944,513$14,074,7720.96%
Kynam Capital Management, LP 1,068,527$5,107,5590.84%
Green Alpha Advisors, LLC 110,524$528,3050.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,500,000$16,730,0000.37%
Bruce & Co., Inc. 200,000$956,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders